Feng Tian

Feng Tian

Auto-generated profile, based on publicly available information

Feng Tian

Department of Gastroenterology, Shengjing Hospital of China Medical University , Shenyang , China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2015 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
TJTianbo Jin
Tianbo Jin
AAAiniwaer Aikemu
Ainiwaer Aikemu
MZMingxi Zhang
Mingxi Zhang
TGTingting Geng
Tingting Geng
TFTian Feng
Tian Feng
MLMan Luo
Man Luo
BACKGROUND:Genetic polymorphisms have a potential clinical role in determining both inter-individual and inter-ethnic differences in drug efficacy, but we have not found any pharmacogenomics information regarding minorities, such as the Miao ethnic g...

30 May 2019 in Genetic Testing and Molecular Biomarkers
Verified
Journal Article
Open access
JYJie Yang
Jie Yang
JWJunhu Wang
Junhu Wang
XLXiaojun Liang
Xiaojun Liang
HZHongmou Zhao
Hongmou Zhao
JLJun Lu
Jun Lu
FTFeng Tian
Feng Tian
Background: Hallux valgus (HV) is a type of forefoot deformity affecting ∼23% of adults. Previous studies have shown that HV is highly heritable. Tumor necrosis factor ( TNF ) is an important proinflammatory cytokine involved in bone remodeling and plays essential roles in osteoarthritis and chronic inflammatory bone diseases, including HV. Methods: A total of 1,788 Chinese women comprising 637 HV subjects and 1,151 controls were recruited. Twelve single nucleotide polymorphisms (SNPs) located in TNF and its promoter regions were selected and genotyped. Genetic association analyses were performed to investigate potential susceptibility SNPs. Bioinformatic and expression quantitative trait loci (eQTL) analyses were conducted to examine the functional consequences of the SNPs identified as being significantly associated with HV. Results: SNP rs1800629, which is located at the 5′ end of the promoter region of TNF , was identified as significantly associated with HV status in Chinese women (OR = 0.56, p = 2.12 × 10 −6 ). Bioinformatic analyses using RegulomeDB indicated that this SNP has important functional significance, but subsequent eQTL analyses did not identify a significant association between rs1800629 and TNF gene expression. In addition, 26 genes with cis-eQTL for rs1800629 were identified. Conclusions: This study identified a susceptibility SNP for HV located within the promoter region of the TNF gene. Bioinformatic and eQTL analyses linked this SNP to 26 genes but not to TNF . Functional studies are needed to more fully characterize the effects of this SNP.

4 February 2022 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
YXYing Xie
Ying Xie
HLHui Li
Hui Li
LZLinyan Zhou
Linyan Zhou
FTFeng Tian
Feng Tian
To the Editors, Vedolizumab is a gut-selected humanized α4β7 integrin antibody, which reduces intestinal inflammation by inhibiting lymphocyte migration to the gut. Recently, vedolizumab has been increasingly used in the treatment of moderately to severely active ulcerative colitis (UC). Vedolizumab safety assessment showed a high safety profile with low incidence rates of serious infections, malignancy events, and <5% of infusion-related reactions.1 The results from the vedolizumab GEMINI long-term safety (LTS) study have further established its safety.2 Here, we report a case of acute allergic reaction following the fifth infusion of vedolizumab in a patient with refractory UC. A 26-year-old woman with a history of UC for 10 years, who was refractory to corticosteroids, received 4 doses of vedolizumab (300 mg) for 15 weeks. The patient experienced severe abdominal colic, shortness of breath, dizziness, and numbness in the limbs after 5 minutes of intravenous (IV) administration of fifth vedolizumab...


27 May 2022 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
LZLinyan Zhou
Linyan Zhou
FTFeng Tian
Feng Tian
HZHong Zhang
Hong Zhang
HSHong Shu
Hong Shu
YGYuying Gao
Yuying Gao
YXYing Xie
Ying Xie
To the Editors: Idiopathic myointimal hyperplasia of the mesenteric veins (IMHMV) is a rare cause of ischemic colitis and enteritis, first described by Genta et al.1 Here, we report a case of IMHMV in China that was initially misdiagnosed as ulcerative colitis (UC). A 67-year-old man presented to our institution with progressive bloody diarrhea over the past 6 months, with protracted abdominal pain and significant weight loss. Colonoscopy revealed an erythematous and edematous sigmoid and descending colon without rectal lesions. Abdominal computed tomography (CT) revealed diffuse thickening of the sigmoid colon and upper rectal walls ( Figure 1A). The patient was diagnosed with UC and started on oral 5-aminosalicylic acid (5-ASA). A week after 5-ASA administration, he developed a nonfebrile rash and discontinued 5-ASA. Upon re-examination, the patient was found to have lost 7% of his body weight. Abdominal examination revealed left lower abdominal tenderness with rebound tenderness. Routine blood tests were unremarkable. His C-reactive protein level was mildly elevated (10.60 mg/L). A colonoscopy revealed a significantly narrowed lumen at the distal 20 cm of the colon, with severe erosions and edema ( Figure 1B). Biopsy specimens demonstrated chronic inflammation and ischemic changes. Subsequent CT demonstrated progression of the diffuse thickening on intestinal walls ( Figure 1C). Endoscopic ultrasound revealed the disappearance of the 5-layer structures of the intestinal wall ( Figure 1D). The patient underwent left hemicolectomy. Resected specimens consisted of a rigid and contracted 25-cm segment of the upper rectum and sigmoid colon with constricted cavities and indurated mesenteric fat ( Figure 1E and 1F). Massive multifocal ischemic changes, crypt distortion, mucosal proliferation, and focal ulcer formation were observed ( Figure 1G). Fibrin thrombi in the blood capillaries, capillary occlusion, and subendothelial deposits of fibrin were seen in the mucous membranes ( Figure 1H). Edema and occlusion of the venous lumen were observed ( Figure 1I). Capillaries underwent “arterialization” ( Figure 1J). The final diagnosis of IMHMV was confirmed by postoperative pathology.

1 February 2020 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
JZJun-Wei Zhang
Jun-Wei Zhang
FTFeng Tian
Feng Tian
BLBing-Qi Li
Bing-Qi Li
YWYi-Zhi Wang
Yi-Zhi Wang
JGJun-Chao Guo
Jun-Chao Guo
Mirizzi syndrome, known as extrinsic bile compression syndrome (EBCS), is difficult to diagnose without surgery. To the best of our knowledge, our case shows that air in the biliary duct may indicate Type V Mirizzi syndrome. A 48-year-old Chinese male, complaining of anorexia with weight loss and jaundice, showed decreased bilirubin for two months after being diagnosed with gallbladder stones. Upon re-examination of the CT, evidence of air in the biliary duct was discovered. Type V EBCS was finally diagnosed during surgery. The patient underwent cholecystectomy, cholecystocolic fistula excision, and Roux-en-Y choledochojejunostomy. The postoperative course was uneventful. Mirizzi’s syndrome is a condition which is difficult to diagnose and treat. Air in the biliary duct can be a sign of Type V Mirizzi syndrome, which aids in diagnosis of Type V EBCS before surgery. Cholecystectomy, fistula excision and biliary-enteric anastomosis with Roux-en-Y loop appear to be the most appropriate surgical interventions for the condition.